Literature DB >> 30481777

Skeletal Morbidity in Children and Adolescents during and following Cancer Therapy.

Sogol Mostoufi-Moab1, Leanne M Ward2.   

Abstract

Skeletal abnormalities are common in children and adolescents diagnosed and treated for a malignancy. The spectrum ranges from mild pain to debilitating osteonecrosis and fractures. In this review, we summarize the impact of cancer therapy on the developing skeleton, provide an update on therapeutic strategies for prevention and treatment, and discuss the most recent advances in musculoskeletal research. Early recognition of skeletal abnormalities and strategies to optimize bone health are essential to prevent long-term skeletal sequelae and diminished quality of life in childhood cancer survivors.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Acute lymphoblastic leukemia; Chemotherapy; Fractures; Hematopoietic stem cell transplantation; Osteochondroma; Osteonecrosis; Radiotherapy; Retinoids

Year:  2018        PMID: 30481777      PMCID: PMC6536370          DOI: 10.1159/000494809

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  11 in total

Review 1.  [Osteonecrosis-severe side effect of treatment for acute lymphoblastic leukemia].

Authors:  Michaela Kuhlen; Marina Kunstreich; Nicola Gökbuget; Gabriele Escherich
Journal:  Orthopadie (Heidelb)       Date:  2022-09-07

2.  A long-term trajectory of bone mineral density in childhood cancer survivors after discontinuation of treatment: retrospective cohort study.

Authors:  Eryk Latoch; Jerzy Konstantynowicz; Maryna Krawczuk-Rybak; Anna Panasiuk; Katarzyna Muszyńska-Rosłan
Journal:  Arch Osteoporos       Date:  2021-02-26       Impact factor: 2.617

3.  Bone morbidity in pediatric acute lymphoblastic leukemia.

Authors:  Moon Bae Ahn; Byung-Kyu Suh
Journal:  Ann Pediatr Endocrinol Metab       Date:  2020-03-31

Review 4.  Pain Management in Childhood Leukemia: Diagnosis and Available Analgesic Treatments.

Authors:  Flaminia Coluzzi; Monica Rocco; Rula Green Gladden; Pietro Persiani; Laurel A Thur; Filippo Milano
Journal:  Cancers (Basel)       Date:  2020-12-07       Impact factor: 6.639

5.  The Impact of a Precision-Based Exercise Intervention in Childhood Hematological Malignancies Evaluated by an Adapted Yo-Yo Intermittent Recovery Test.

Authors:  William Zardo; Emanuele Villa; Eleonora Corti; Tommaso Moriggi; Giorgia Radaelli; Alessandra Ferri; Mauro Marzorati; Cristiano Eirale; Paola Vago; Andrea Biondi; Momcilo Jankovic; Adriana Balduzzi; Francesca Lanfranconi
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

6.  Low bone mineral density can occur in children after shortterm systemic glucocorticoid treatment.

Authors:  Moon Bae Ahn
Journal:  Clin Exp Pediatr       Date:  2022-04-27

Review 7.  Osteoporosis in children and adolescents: when to suspect and how to diagnose it.

Authors:  Silvia Ciancia; Rick R van Rijn; Wolfgang Högler; Natasha M Appelman-Dijkstra; Annemieke M Boot; Theo C J Sas; Judith S Renes
Journal:  Eur J Pediatr       Date:  2022-04-06       Impact factor: 3.860

8.  Effect of Vertebral Fracture on Auxological Profiles of Children Undergoing Acute Lymphoblastic Leukemia Treatment.

Authors:  Moon Bae Ahn; Seongkoo Kim; Won Kyoung Cho; Jae Wook Lee; Min Ho Jung; Nack-Gyun Chung; Bin Cho; Byung-Kyu Suh
Journal:  Front Pediatr       Date:  2021-06-16       Impact factor: 3.418

Review 9.  Recent perspectives on the association between osteonecrosis and bone mineral density decline in childhood acute lymphoblastic leukemia.

Authors:  Jenneke E van Atteveld; Demi Tc de Winter; Rob Pieters; Sebastian Jcmm Neggers; Marry M van den Heuvel-Eibrink
Journal:  Fac Rev       Date:  2021-06-23

10.  Osteopathic Treatment and Evaluation in the Clinical Setting of Childhood Hematological Malignancies.

Authors:  Monica Barbieri; William Zardo; Chiara Frittoli; Clara Rivolta; Valeria Valdata; Federico Bouquin; Greta Passignani; Alberto Maggiani; Momcilo Jankovic; Andrea Cossio; Andrea Biondi; Adriana Balduzzi; Francesca Lanfranconi
Journal:  Cancers (Basel)       Date:  2021-12-16       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.